SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-082184
Filing Date
2015-03-09
Accepted
2015-03-09 09:04:59
Documents
5
Period of Report
2015-03-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889593d8k.htm 8-K 15612
2 EX-99.1 d889593dex991.htm EX-99.1 36657
3 GRAPHIC g889593ex99_1s1gbgd.jpg GRAPHIC 24499
4 GRAPHIC g889593ex99_1s2gbgd.jpg GRAPHIC 29107
5 GRAPHIC g889593ex99_1s3gbgd.jpg GRAPHIC 25099
  Complete submission text file 0001193125-15-082184.txt   162525
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15683580
SIC: 2834 Pharmaceutical Preparations